ASIARAY (01993): Ma Zhaoxiang resigns as an independent non-executive director.
Yashowei (01993) announced that Mr. Ma Zhaoxiang has decided not to seek re-election as an independent non-executive director at the annual general meeting of shareholders. Therefore, Mr. Ma will step down from his position as an independent non-executive director immediately after the annual general meeting. As a result, Mr. Ma will no longer serve as an independent non-executive director, chairman of the audit committee, or member of the remuneration committee, effective immediately after the annual general meeting.
ASIARAY (01993) announced that Mr. Ma Zhaoxiang has decided not to seek re-election as an independent non-executive director at the annual general meeting of shareholders. Therefore, he will resign from the position of independent non-executive director immediately after the annual general meeting of shareholders. As a result, Mr. Ma will no longer serve as an independent non-executive director, chairman of the audit committee, or member of the remuneration committee, effective immediately after the annual general meeting of shareholders.
Related Articles

Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?

New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.

How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!
Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?

New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.

How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!

RECOMMEND





